{"id":"W1979497236","doi":"10.1038/leu.2011.329","title":"Oral high-dose glucocorticoids and Ofatumumab in fludarabine-resistant Chronic Lymphocytic Leukemia","year":2011,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Health Canada; GlaxoSmithKline","keywords":"Ofatumumab; Fludarabine; Chronic lymphocytic leukemia; Medicine; Leukemia; Vidarabine; Internal medicine; Oncology; Cancer research; Immunology; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0007758776,0.001591408,0.002735622,0.001318474,0.0001920345,0.0001815167,0.001348446,0.003169204,0.001197278],"category_scores_gemma":[0.0006666225,0.001457498,0.0004770459,0.001130848,0.001150156,0.0003017664,0.001153506,0.005440549,0.0008691481],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.4700154,"about_ca_system_score_gemma":0.1582789,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04064221,"about_ca_topic_score_gemma":0.001359578,"domain_scores_codex":[0.9905103,0.0003688676,0.001863058,0.002365489,0.002010774,0.002881485],"domain_scores_gemma":[0.9944288,0.000482791,0.0005179214,0.00360714,0.0002962208,0.0006670941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002554963,0.00006147171,0.0001665419,0.006527341,0.0006824097,0.04415811,0.0005241443,0.0001217268,0.002932778,0.0002895804,0.9344823,0.007498603],"study_design_scores_gemma":[0.1616503,0.003498897,0.005526613,0.006563437,0.001784754,0.006489188,0.0001042295,0.03035436,0.004712284,0.002599142,0.7723844,0.004332361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.921935,0.01465018,0.00004258952,0.04019916,0.002180939,0.006144001,0.0002396219,0.000982357,0.01362618],"genre_scores_gemma":[0.6102299,0.004863479,0.002524997,0.3018336,0.01366518,0.001513339,0.002789614,0.001723182,0.0608567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3117365,"threshold_uncertainty_score":0.9999088,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02322131647054599,"score_gpt":0.2723016917277518,"score_spread":0.2490803752572058,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}